.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Theraplant is stocked at 50 licensed dispensaries across Connecticut, with the deepest coverage in Hamden, New Haven, Norwalk, West Hartford, and Bristol. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Theraplant's mix in October 2026 concentrated in Pre-Roll at 30.7% share and Vapor Pens at 30.3%, with Flower close behind at 29.8%, but the growth vectors diverged: Pre-Roll fell 27.4% month over month and 16.0% year over year, Vapor Pens contracted 22.6% MoM and 61.7% YoY, while Flower rose 9.8% MoM despite a 28.1% YoY decline. Smaller formats pivoted upward, with Tincture & Sublingual up 23.4% MoM and 37.0% YoY to 2.9% share, and Capsules up 7.4% MoM but down 42.9% YoY to 5.4% share; even Concentrates rebounded 136.2% MoM after an 86.7% YoY collapse, albeit at 0.4% share. Coupled with a 25.9% YoY drop in average price and a brand-level YoY sales decline of 41.9%, the pattern implies a defensive shift toward lower-priced or utility formats to stabilize volume while higher-ticket inhalables retrench.
The mix and pricing shifts suggest Theraplant is prioritizing accessibility within Connecticut, leaning on Pre-Roll leadership (rank 1) while absorbing Vapor Pens' 61.7% YoY contraction and using Flower’s 9.8% MoM lift as a near-term buffer. The simultaneous expansion of Tincture & Sublingual by 37.0% YoY and Capsules’ 7.4% MoM gain, alongside a 25.9% YoY price compression, indicates repositioning toward value and medical-adjacent use cases that are less exposed to premium vape elasticity. The thesis is that maintaining rank 1 in Pre-Roll while nudging up non-inhalable share creates a barbell that can offset Vape volatility, but the October 2026 MoM declines in Pre-Roll (27.4%) and Vapor Pens (22.6%) signal that sustaining total share will require continued emphasis on Flower momentum and further price-pack architecture improvements.
Competitive Landscape
Theraplant is ranked #1 in CT Pre-Roll in October 2026, improving 1 position from #2 year over year, and it has held #1 for the past three months while peaking at #1 in October 2026; in contrast, Comffy moved from #6 to #2 alongside a 72.8% year-over-year sales increase, and Grassroots advanced from #13 to #5 with a 382.6% year-over-year sales gain, indicating faster chasers just below the top. The directional gap is narrowing as Theraplant’s YoY rank change is +1 while Comffy’s is +4 and Grassroots’s is +8, and the three-month stability at #1 versus rivals’ multi-rank ascents suggests current leadership relies more on sustained consistency than acceleration; the pattern implies Theraplant’s trajectory points to maintained leadership that will require defensive moves against rapidly advancing #2 and #5 contenders.
Notable Products
October 2026 was driven by fresh launches: 88 new products accounted for 50.6% of Theraplant’s sales, and several appear in the top sellers such as Mean Muggin Pure CO2 Mini Tank Disposable (0.5g) and Strawberry Cndy (3.5g). That weight on recent introductions means a large share of revenue comes from items added in the last six months, not long-running staples.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
